Literature DB >> 9924306

Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications.

C Frennesson1, S E Nilsson.   

Abstract

AIM: To investigate the effect of prophylactic laser treatment on drusen area and incidence of exudative lesions in patients with soft drusen maculopathy.
METHODS: In a prospective study, patients with early age related maculopathy (ARM) and good visual acuity were randomized to laser treatment or to a control group. Each group consisted of two subgroups: a fellow eye group and a bilateral drusen group. At 3 years, 36 of 38 enrolled patients remained in the study. Photocoagulation was performed with an argon green laser, approximately 100 mild laser burns being placed on and between the drusen in a perifoveal temporal horseshoe-shaped area. Both cases and controls were subjected to fundus colour photographs and fluorescein angiograms at regular intervals, and the drusen area was calculated in both photographs and angiograms. At baseline, there were no significant differences (p > 0.3-0.8) in drusen area between the groups.
RESULTS: In the treatment group, mean drusen area decreased significantly in the fundus photographs as well as in the angiograms (p < 0.001). Visual acuity and colour contrast sensitivity (CCS) did not change significantly. All these results are valid also for the subgroups. In the control group, however, mean drusen area increased significantly (p < 0.001). Mean visual acuity decreased significantly (p < 0.01) as did the colour contrast sensitivity along the tritan axis (p = 0.02). For the fellow eye control group (n = 7), the increase in drusen area in fundus photographs and the decrease in CCS along the tritan axis were not statistically significant (p = 0.57 and p = 0.37, respectively). Furthermore, at 3 years, five patients in the control group showed exudative lesions (1/7 in the fellow eye group and 4/12 in the bilateral drusen group), whereas no such complications occurred in the treatment group. One patient developed a small atrophy, however. Thus, there is now a significant difference (p = 0.047), however with a large 95% confidence interval, 0.06-0.46, regarding exudative complications between the treated group and the control group in our small patient material.
CONCLUSION: Perifoveal mild laser treatment causes a reduction in drusen area in patients with soft drusen maculopathy and may lower the incidence of exudative lesions.

Entities:  

Mesh:

Year:  1998        PMID: 9924306      PMCID: PMC1722362          DOI: 10.1136/bjo.82.10.1169

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  25 in total

1.  A survey of color discrimination in German ophthalmologists. Changes associated with the use of lasers and operating microscopes.

Authors:  G B Arden; T Berninger; C R Hogg; S Perry
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

2.  Drusen and disciform macular detachment and degeneration.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1973-09

3.  Repair of the pigment epithelial barrier following photocoagulation.

Authors:  I H Wallow
Journal:  Arch Ophthalmol       Date:  1984-01

4.  Prognosis of patients with bilateral macular drusen.

Authors:  W E Smiddy; S L Fine
Journal:  Ophthalmology       Date:  1984-03       Impact factor: 12.079

5.  Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study.

Authors:  J Duvall; M O Tso
Journal:  Arch Ophthalmol       Date:  1985-05

6.  Pathogenesis of laser-induced choroidal subretinal neovascularization.

Authors:  H Miller; B Miller; T Ishibashi; S J Ryan
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-05       Impact factor: 4.799

7.  Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group.

Authors:  S B Bressler; M G Maguire; N M Bressler; S L Fine
Journal:  Arch Ophthalmol       Date:  1990-10

8.  Prophylactic photocoagulation of the fellow eye in exudative senile maculopathy. A preliminary report.

Authors:  G W Cleasby; A S Nakanishi; J L Norris
Journal:  Mod Probl Ophthalmol       Date:  1979

9.  The second eye of patients with senile macular degeneration.

Authors:  E R Strahlman; S L Fine; A Hillis
Journal:  Arch Ophthalmol       Date:  1983-08

10.  Foveal drusen resorption one year after perifoveal laser photocoagulation.

Authors:  J Sigelman
Journal:  Ophthalmology       Date:  1991-09       Impact factor: 12.079

View more
  17 in total

Review 1.  Statement and supplementary statement from the BVA, the DOG, and the RG on laser treatment of drusen in age-related macular degeneration (AMD) : August 2017, update October 2018.

Authors: 
Journal:  Ophthalmologe       Date:  2020-01       Impact factor: 1.059

Review 2.  [Statement from the BVA, the DOG and the RG on laser treatment of drusen in age-related macular degeneration (AMD) : August 2017].

Authors: 
Journal:  Ophthalmologe       Date:  2017-11       Impact factor: 1.059

Review 3.  Prophylactic laser in age-related macular degeneration: the past, the present and the future.

Authors:  Quan Findlay; Andrew I Jobling; Kirstan A Vessey; Ursula Greferath; Joanna A Phipps; Robyn H Guymer; Erica L Fletcher
Journal:  Eye (Lond)       Date:  2018-03-09       Impact factor: 3.775

Review 4.  Laser photocoagulation as treatment of non-exudative age-related macular degeneration: state-of-the-art and future perspectives.

Authors:  Giuseppe Querques; Maria Vittoria Cicinelli; Alessandro Rabiolo; Luigi de Vitis; Riccardo Sacconi; Lea Querques; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-25       Impact factor: 3.117

5.  An interinstitutional comparative study and validation of computer aided drusen quantification.

Authors:  V Sivagnanavel; R T Smith; G B Lau; J Chan; C Donaldson; N V Chong
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

Review 6.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

Review 7.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

8.  Colour vision testing as an aid to diagnosis and management of age related maculopathy.

Authors:  G B Arden; J E Wolf
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

9.  Photodynamic therapy treatment for eyes with drusenoid pigment epithelium detachment.

Authors:  Na Young Lee; Ki Seok Kim
Journal:  Korean J Ophthalmol       Date:  2008-09

10.  Effect of laser treatment for dry age related macular degeneration on foveolar choroidal haemodynamics.

Authors:  M Figueroa; L S Schocket; J DuPont; T I Metelitsina; J E Grunwald
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.